101 Results for "

Smo

" in MedChemExpress (MCE) Product Catalog:
Products (101)

101 Results for "Smo" in MCE Product Catalog:

  • Categories Recommended:
    More
60
60 Publications Verification
Cat. No.: HY-17024
CAS No.: 4449-51-8
Synonyms: 11-Deoxojervine
Cyclopamine is a Hedgehog (Hh) pathway antagonist with an IC50 of 46 nM in the Hh cell assay. Cyclopamine is also a selective Smo inhibitor.
loading...
    loading...
47
47 Cited Publications
Cat. No.: HY-12848
CAS No.: 912545-86-9
Purity:  99.60%
Target:  

Smo

Research Areas:  

Cancer

SAG is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=59 nM). SAG activates the Hedgehog signaling pathway and counteracts Cyclopamine (HY-17024) inhibition of Smo .
loading...
    loading...
47
47 Cited Publications
Cat. No.: HY-12848B
CAS No.: 2095432-58-7
Purity:  99.91%
Target:  

Smo

Research Areas:  

Cancer

SAG hydrochloride is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=59 nM). SAG hydrochloride activates the Hedgehog signaling pathway and counteracts Cyclopamine (HY-17024) inhibition of Smo .
loading...
    loading...
47
47 Cited Publications
Cat. No.: HY-12848C
CAS No.: 2702366-44-5
Purity:  99.31%
Target:  

Smo

Research Areas:  

Cancer

SAG dihydrochloride is a potent Smoothened (Smo) receptor agonist (EC50=3 nM; Kd=59 nM). SAG dihydrochloride activates the Hedgehog signaling pathway and counteracts Cyclopamine (HY-17024) inhibition of Smo .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-15108
CAS No.: 483367-10-8
Purity:  99.9%
Target:  

Organoid Smo Autophagy

Research Areas:  

Neurological Disease Cancer

Purmorphamine is a smoothened/Smo receptor agonist with an EC50 of 1 μM.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-16582A
CAS No.: 956697-53-3
Synonyms: EriSmodegib; LDE225; NVP-LDE225
Target:  

Smo

Research Areas:  

Cancer

Sonidegib (Erismodegib) is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-16582
CAS No.: 1218778-77-8
Synonyms: EriSmodegib diphosphate; LDE225 diphosphate; NVP-LDE225 diphosphate
Target:  

Smo

Research Areas:  

Cancer

Sonidegib diphosphate (Erismodegib diphosphate) is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-16391
CAS No.: 1095173-27-5
Synonyms: PF-04449913
Target:  

Smo

Research Areas:  

Cancer

Glasdegib (PF-04449913) is a potent and orally bioavailable smoothened inhibitor. Glasdegib (PF-04449913) binds to human SMO (amino acids 181-787) with an IC50 of 4 nM .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15483
CAS No.: 95167-41-2
Purity:  99.22%
Synonyms: GSK 9089
Research Areas:  

Endocrinology Cancer

DY131 (GSK 9089) is a potent and selective ERRγ and ERRβ agonist. DY131displays inactive against ERRα, ERα and ERβ . DY131 also inhibits Smo signaling .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-12316
CAS No.: 516-72-3
Purity:  99.29%
Synonyms: 20α-Hydroxycholesterol
20(S)-Hydroxycholesterol (20α-Hydroxycholesterol) is an allosteric activator that selectively targets the Smoothened (Smo) of the Hedgehog pathway with an EC50 of ~30 μM (Hedgehog). 20(S)-Hydroxycholesterol binds to the extracellular cysteine-rich domain (CRD) of Smo in a stereoselective manner, activating downstream Gli transcription factors (without inducing transcription of receptor genes in the Wnt pathway). 20(S)-Hydroxycholesterol enhances osteogenic differentiation of bone marrow stromal cells and synergistically activates the Raf/MEK/ERK pathway with Simvastatin (HY-17502) to promote bone regeneration. 20(S)-Hydroxycholesterol can be used to study the mechanisms of developmental biology, oncology, bone, and angiogenesis .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100224
CAS No.: 304909-07-7
Purity:  99.81%
Target:  

Smo Hedgehog

Research Areas:  

Cancer

SANT-1, a potent Smo antagonist, inhibits Hedgehog signaling. SANT-1 shows IC50s of 20 nM and 30 nM in Shh-LIGHT2 and SmoA1-LIGHT2 assay, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100515
CAS No.: 1132653-79-2
Purity:  99.42%
Target:  

Hedgehog

Research Areas:  

Inflammation/Immunology

Robotnikinin is a small molecule capable of binding to and inhibiting the activity of Sonic Hedgehog (Shh) signaling up stream of Smo .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13242
CAS No.: 1258861-20-9
Purity:  99.92%
Synonyms: LY2940680; ENV-101
Target:  

Smo Gli

Research Areas:  

Cancer

Taladegib (LY2940680) is a Smoothened (SMO) antagonist. Taladegib hydrochloride inhibits the Hedgehog signaling pathway, with an IC50 of 5.5 nM for suppressing GLI1 mRNA expression in DAOY cells and an IC50 of 7.6 nM in CGNP cell proliferation assays. Taladegib binds to the extracellular loop region (site 1) of the transmembrane domain of the SMO receptor, competes with cyclopamine for SMO binding, and thereby inhibits Gli-dependent transcription. Taladegib can be used in studies of Hedgehog pathway-related cancers .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-100535
CAS No.: 306387-90-6
Synonyms: Cyclopamine-KAAD
Target:  

Smo

Research Areas:  

Cancer

KAAD-Cyclopamine, a hedgehog signaling inhibitor, is a smoothened antagonist .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0247
CAS No.: 58558-08-0
Saikosaponin B1 is a bioactive constituent of Radix Bupleuri. Saikosaponin B1 is an agonist of the 5-HT2C receptor with an EC50 of 147.41 μM. Saikosaponin B1 inhibits the Hedgehog (Hh) signaling pathway by targeting the transmembrane protein SMO. Sailosaponin B1 can reduce liver fibrosis. Saikosaponin B1 has anti-cancer activities thus can be studies in research for cancers such as Medulloblastoma (MB) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19642A
CAS No.: 2319837-80-2
Synonyms: MGCD265 hydrochloride
Target:  

TAM Receptor c-Met/HGFR

Research Areas:  

Cancer

Glesatinib hydrochloride (MGCD265 hydrochloride) is an orally active, potent MET/SMO dual inhibitor. Glesatinib hydrochloride, a tyrosine kinase inhibitor, antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13242A
CAS No.: 1258861-21-0
Synonyms: LY2940680 hydrochloride
Target:  

Smo Gli

Research Areas:  

Cancer

Taladegib (LY2940680) hydrochloride is a Smoothened (SMO) antagonist. Taladegib hydrochloride inhibits the Hedgehog signaling pathway, with an IC50 of 5.5 nM for suppressing GLI1 mRNA expression in DAOY cells and an IC50 of 7.6 nM in CGNP cell proliferation assays. Taladegib hydrochloride binds to the extracellular loop region (site 1) of the transmembrane domain of the SMO receptor, competes with cyclopamine for SMO binding, and thereby inhibits Gli-dependent transcription. Taladegib hydrochloride can be used in studies of Hedgehog pathway-related cancers .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0877
CAS No.: 3093-35-4
Synonyms: SQ-18566
Halcinonide (SQ-18566) is an orally active Smoothened (Smo) agonist. Halcinonide activates the Hedgehog signaling pathway by binding to Smo and promoting its internalization and expression, thereby activating Gli transcription factors. Halcinonide not only stimulates cell proliferation, increases the expression of cyclin D2/CDK6 and inhibits the degradation of caspase-3, but also suppresses Bcl-2/Bax-mediated apoptosis, oxidative stress and inflammatory responses. Halcinonide activates RxRγ to upregulate the expression of myelin genes, thereby reducing cerebral infarction and improving behavioral deficits. Halcinonide has been used in studies related to multiple sclerosis and ischemic stroke .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15412
CAS No.: 496794-70-8
Purity:  99.40%
Target:  

Smo

Research Areas:  

Cancer

HhAntag is a specific, potent and orally active small molecule SMO antagonist of the Hh pathway .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15108G
CAS No.: 483367-10-8
Purmorphamine (GMP) is Purmorphamine (HY-15108) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Purmorphamine is a smoothened/Smo receptor agonist with an EC50 of 1 μM .
loading...
    loading...